Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications
Introduction: There is an urgent need for health authorities across Europe to fully realise potential savings from increased use of generics to sustain their healthcare systems. A variety of strategies were used across Europe following the availability of generic losartan, the first angiotensin rece...
Saved in:
Main Authors: | James eMoon (Author), Brian eGodman (Author), Max ePetzold (Author), Samantha eAlvarez-Madrazo (Author), Kathleen eBennett (Author), Iain eBishop (Author), Anna eBucsics (Author), Ulrik eHesse (Author), Andrew eMartin (Author), Steven eSimoens (Author), Corinne eZara (Author), Rickard E Malmstrom (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
by: Brian eGodman, et al.
Published: (2014) -
Potential to enhance the prescribing of generic drugs in patients with mental health problems in Austria; implications for the future
by: Brian eGodman, et al.
Published: (2013) -
Policies to enhance prescribing efficiency in Europe: findings and future implications
by: Brian eGodman, et al.
Published: (2011) -
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimise the use of new drugs
by: Rickard eMalmstrom, et al.
Published: (2013) -
Dabigatran - an exemplar case history demonstrating the need for comprehensive models to optimise the use of new drugs
by: Brian eGodman, et al.
Published: (2014)